Abstract
To obtain a consensus on the minimal clinically relevant treatment effect in various scleroderma disease outcome measures to be used in future clinical trials.
Original language | English |
---|---|
Pages (from-to) | 501-509 |
Number of pages | 9 |
Journal | Journal of Rheumatology |
Volume | 34 |
Issue number | 3 |
Publication status | Published - 2007 |